Clincosm LogoSign in Get a demo

hodgkin's lymphoma

Showing 26 - 50 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Women Who Survived Cancer orRelated Illness Following Total Body

Completed
  • Leukemia
  • +3 more
  • Questionnaires, Laboratory tests, Abdominal MRI
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 3, 2020

Whole-body MRI in Pediatric Hodgkin's Lymphoma

Completed
  • Hodgkin's Lymphoma
    • Graz, Austria
    • +7 more
    Nov 2, 2020

    Hodgkin's Lymphoma Trial in Maywood (Temsirolimus)

    Terminated
    • Hodgkin's Lymphoma
    • Maywood, Illinois
      Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
    Sep 14, 2020

    Hodgkin's Lymphoma Trial in Moscow, Saint Petersburg (Brentuximab Vedotin)

    Recruiting
    • Hodgkin's Lymphoma
    • Brentuximab Vedotin
    • Moscow, Russian Federation
    • +1 more
    Jul 20, 2020

    Hodgkin's Lymphoma Trial in Saint-Petersburg (Nivolumab, Bendamustine Hydrochloride)

    Completed
    • Hodgkin's Lymphoma
    • Saint-Petersburg, Russian Federation
      First Pavlov State Medical University of St. Petersburg
    May 27, 2020

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (GCSF, meloxicam, Placebo)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 15, 2020

    Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

    Completed
    • Hematological Neoplasms
    • +19 more
    • Scottsdale, Arizona
    • +9 more
    May 11, 2020

    Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

    Terminated
    • Non-Hodgkin's Lymphoma
    • +4 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 12, 2020

    Hodgkin's Lymphoma, Mature T-cell Lymphoma, Multiple Myeloma Trial in New Haven (lenalidomide (Revlimid) and romidepsin

    Terminated
    • Hodgkin's Lymphoma
    • +2 more
    • lenalidomide (Revlimid) and romidepsin (Istodax)
    • New Haven, Connecticut
      Yale Cancer Center
    Mar 2, 2020

    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

    Completed
    Has Results
    • Relapsed or Refractory Lymphoproliferative Malignancies
    • +4 more
    • Pralatrexate Injection
    • +3 more
    • Los Angeles, California
    • +14 more
    Dec 27, 2019

    Hodgkin's Lymphoma, Leukemia, Lymphoid Leukemia Trial in Madison (Behavioral techniques)

    Completed
    • Hodgkin's Lymphoma
    • +6 more
    • Behavioral techniques
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Nov 14, 2019

    Hodgkin's Lymphoma Trial in United States (Entinostat)

    Terminated
    Has Results
    • Hodgkin's Lymphoma
    • Beverly Hills, California
    • +5 more
    Oct 3, 2019

    Hodgkin's Lymphoma Trial in United States (TGR-1202 + brentuximab vedotin)

    Completed
    • Hodgkin's Lymphoma
    • TGR-1202 + brentuximab vedotin
    • Duarte, California
    • +3 more
    Oct 1, 2019

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma Trial in Minneapolis (852A)

    Terminated
    Has Results
    • Acute Lymphoblastic Leukemia
    • +5 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Aug 21, 2019

    FLT PET: A Pilot Study in Lymphoma Patients

    Completed
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • FDG PET
    • FLT PET
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Jul 22, 2019

    Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease Trial run by the NCI (Rituximab, Cyclosporine, Allogenic

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +4 more
    • Rituximab
    • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Feb 11, 2019

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Dec 29, 2018

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    Has Results
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Hodgkin's Lymphoma Trial in Beijing (AK105)

    Unknown status
    • Hodgkin's Lymphoma
    • AK105
    • Beijing, Beiing, China
      Beijing Cancer Hospital
    Oct 26, 2018

    Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS) Trial in Baltimore (drug, radiation, biological)

    Completed
    • Hodgkin's Lymphoma
    • +4 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Oct 12, 2018

    Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

    Completed
    Has Results
    • Breast Cancer
    • +15 more
    • Encinitas, California
    • +23 more
    Sep 20, 2018

    Hodgkin's Lymphoma Trial in New York (ABVD chemo)

    Terminated
    Has Results
    • Hodgkin's Lymphoma
    • ABVD chemotherapy
    • New York, New York
      Weill Cornell Medical College
    Aug 3, 2018

    Hodgkin's Lymphoma Trial in Belgium, France (Ruxolitinib)

    Completed
    • Hodgkin's Lymphoma
    • Brussels, Belgium
    • +9 more
    Aug 21, 2018

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • CliniMACS® CD34 Reagent System
    • +5 more
    • New York, New York
      Weill Cornell Medical College
    Jun 12, 2018

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemias Trial run by the NCI (Single fraction radiation, Donor

    Terminated
    Has Results
    • Hodgkin's Lymphoma
    • +3 more
    • Single fraction radiation
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 30, 2018